SCHEMBL8874457

SCHEMBL8874457

O=C1Nc2cc(F)cc(F)c2C(=O)C(=O)/C1=N\O

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 2/20 0.37
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
LRRK2 Q5S007 5/20 0.31
AGTR1 P30556 1/20 0.31
KMT2A Q03164 1/20 0.31
CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8874461 1.00 TGM2 (0.37) TGM2CA1CA2LRRK2AGTR1
SCHEMBL8873175 0.88 TGM2 (0.40) TGM2CES1
SCHEMBL8873167 0.88 TGM2 (0.40) TGM2CES1
SCHEMBL8873649 0.81 TGM2 (0.48) TGM2CES1
SCHEMBL1398146 0.79 TGM2 (0.50) TGM2CES1
SCHEMBL29443269 0.79 TGM2 (0.50) TGM2CES1
SCHEMBL8873805 0.75 TGM2 (0.48) TGM2CA1CA2LRRK2AGTR1
SCHEMBL8873796 0.75 TGM2 (0.48) TGM2CA1CA2LRRK2AGTR1
SCHEMBL8873629 0.74 CAPN9 (0.31) CA1CA2KMT2A
SCHEMBL8873624 0.74 CAPN9 (0.31) CA1CA2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597922-A Glycine receptor antagonist pharmacophore STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1997-01-28 US disclosed
WO-1996004288-A1 GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1996-02-15 WO disclosed